Meningitis B stands out as one of the most aggressive bacterial infections teenagers can contract. The disease develops rapidly, sometimes progressing from first symptoms to severe illness within hours. It kills around 10 percent of those infected and leaves permanent disabilities like brain damage, hearing loss, or limb amputations in roughly 20 percent of survivors.

The bacterium, Neisseria meningitidis serogroup B, lives harmlessly in many people's throats but can invade the bloodstream and brain without warning. Teenagers face particular risk because they gather in schools, dormitories, and social settings where the infection spreads through respiratory droplets and saliva.

A vaccine against meningitis B exists and proves highly effective, yet health authorities restrict its availability to specific groups rather than offering it universally. This approach reflects cost considerations and disease prevalence patterns. Most countries prioritize vaccination for teenagers aged 13 to 19, along with students entering university and young military recruits. Some programs also target people with compromised immune systems or those traveling to regions with high meningitis B rates.

The decision to limit vaccine access comes down to public health strategy. While meningitis B causes serious harm, cases remain relatively rare in most developed nations. Universal vaccination programs require substantial funding that health systems allocate based on disease frequency and vulnerable populations. Countries weigh the expense against the number of cases they can prevent.

Teenagers whose parents book private appointments can access the vaccine regardless of eligibility criteria, though costs run between £100 to £200 per dose in the UK.

Healthcare providers emphasize that awareness matters. Parents and teenagers should recognize meningitis B symptoms: severe headache, high fever, stiff neck, rash that doesn't fade under pressure, confusion, and sensitivity to light. Anyone experiencing these signs needs emergency medical attention immediately.

The gap between vaccine availability and disease severity frust